5
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparison of the Dermal Toxicity of four Antimicrobial-Steroid Cream Combinations in the Rabbit

, , , , &
Pages 19-27 | Published online: 27 Sep 2008
 

Abstract

The dermal toxicity of four antimicrobial-steroid cream formulations, tolnaf-tate 1%/hydrocortisone 0.5% (TH), clotrimazole 1%/hydrocortisone 0.5% (CH), clotrimazole 1%/betamethasone 0.06% (CB), and clotrimazole 1%/gentamkin 0.1%/betamethasone 0.05% (CGB), was compared in separate studies. All cream formulations were applied to the intact skin of rabbits for 21–25 consecutive days. For comparison, two control groups were used in each study: one dosed with the appropriate vehicle and one nmfreated group.

The results of these studies have shown that erythema produced on intact rabbit skin by each of the medicated cream formulations was equivalent or slightly less than that produced by each of the corresponding vehicles. There was no significant difference between the medicated and vehicle creams in the time of onset of erythema or in the incidence of edema, atonia, papules, pustules, desquamation, wrinkling, fissuring, or skin thickness. These findings suggest that tolnaftate, hydrocortisone, clotrimazole, gen-tamicin, and betamethasone can be used in combination in topical preparations with no increase in the potential for dermal irritation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.